Delivery Order SPE2DB20D2104-SPE2DB25FNAGX
- Not listed
- The Defense Logistics Agency awarded a $1,143.87 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The order represents a child delivery order under a larger contract vehicle, enabling the pharmaceutical distributor to supply critical medical...
- The Defense Logistics Agency awarded a $3,798.79 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,924.08 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price contract, awarded without set-aside designation through competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $14,455.29 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,149.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The ultimate completion date for this delivery order is September 4, 2025,...
- The Defense Logistics Agency awarded a $70,021.66 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $5,237.35 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,251.60 on August 15, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The contract, designated as a firm fixed price delivery order with an ultimate completion date of August 18, 2025, represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAGXDelivery Order
The Defense Logistics Agency awarded a $68,632.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical procurement needs across military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages its comprehensive IDC with DLA to fulfill federal requirements for a broad portfolio of medications and medical supplies. The company's contract awards demonstrate consistent capability to meet competitive federal procurement standards across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Zepbound, a diabetes medication, exemplifies AmerisourceBergen's role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, supporting medical readiness and healthcare delivery for military personnel and beneficiaries.